Mentioned:
The future of blood samples might be changing in America. And Hims & Hers wants to be on the leading edge of it.
What’s happening:
- Hims & Hers (NYSE: HIMS) is acquiring Boston based blood sampling startup YourBio Health in a new all cash deal
Why it matters:
- YourBio Health has developed leading edge medical devices that allow individuals to perform simple blood sampling at home with very minimal pain or discomfort
Going deeper:
- YourBio Health has received 510(k) clearance from the United States Food and Drug Administration for their blood sample devices and have successfully performed millions of blood draws
- Hims & Hers has publicly stated they plan to make YourBio Health’s devices available to all their existing subscribers upon closing of the acquisition
The intrigue:
- This is not the first time that Hims & Hers has pursued at home blood testing, previously cutting a deal to buy out Trybe Labs
